Insights

Press Coverage | 06.10.25

F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’

Press Coverage | 01.29.25

Experts Expect Tweaks, Not Teardown, For Renewable Credits

Press Coverage | 01.24.25

Law Firms Joust For Attention As Clients Weigh Trump Policy Blitz

Press Coverage | 01.22.25

Trump’s Assault On Biden’s Healthcare Program Starts Quickly

Press Coverage | 01.09.25

How Trump Could Upend A Plan To Police Lab Tests

Press Coverage | 12.02.24

Big Shadows, Including Lighthizer’s, Loom Over Greer Nomination

Press Coverage | 12.02.24

Morning Money: December 2, 2024

Press Coverage | 12.02.24

Weekly Trade: December 2, 2024

Press Coverage | 11.12.24

Trump Pick To Lead EPA Is Loyal, Would Learn On The Job

Press Coverage | 11.11.24

What Trump Presidency Will Mean For Banks' AI projects

Press Coverage | 10.28.24

Generics Anticipate Difficulties As Likely BIOSECURE Passage Looms

Press Coverage | 09.13.24

Bill targeting Chinese biotechs worries U.S. researchers

Press Coverage | 07.12.24

How SCOTUS' Decision In Chevron Could Change The Way The FDA Regulates Biopharma

Press Coverage | 05.08.24

Crowell & Moring Adds Environmental Lobbyist From Van Ness

Press Coverage | 04.19.24

Beltway Moves: Kaplan Hecker, MoFo, Morgan Lewis

Press Coverage | 04.09.24

Crowell & Moring Hires Senior Health Atty From Capital Hill

Press Coverage | 04.09.24

POLITICO Playbook: April 9, 2024

Press Coverage | 04.09.24

POLITICO Pulse: April 9, 2024

Press Coverage | 12.06.23

The Hill’s Top Lobbyists 2023

Press Coverage | 08.16.23

Regular Order Could Snuff Chances For Year-End Tax Package